Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis - Kantarjian, HM; Hughes, TP; Larson, RA (Leukemia, 2021)
et al.